Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1082917

GW&K Investment Management, LLC

Wealth managerFiled 2026-08-12 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$12.8B
Reported positions
1,084
Top holdings a year, 3 yrs
+24.4%
Assets under management
$52.8B

GW&K Investment Management, LLC is a wealth manager that reported 1,084 positions worth $12.8B in its Q2 2026 13F, filed 2026-08-12. Its largest holdings were Macom Tech Solutions Hldgs I (MTSI, 1.9%), Advanced Energy Inds Inc (AEIS, 1.7%), Spx Technologies Inc (SPXC, 1.4%). A portfolio copying its top holdings returned 24.4% a year over the last 3 years, against 20.4% for the S&P 500.

GW&K Investment Management, LLC holdings largest 50 of 1,084 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

GW&K Investment Management, LLC 13F holdings
Stock% of 13F valueShare changeReported value
MTSIMacom Tech Solutions Hldgs I1.9%-24.4%$241.4M
AEISAdvanced Energy Inds Inc1.7%-3.9%$215.5M
SPXCSpx Technologies Inc1.4%+5.7%$175.0M
STRLSterling Infrastructure Inc1.3%-35.1%$165.9M
ITTItt1.2%-4.1%$151.1M
NOVTNovanta Inc1.1%+4.5%$145.6M
ROLLRbc Bearings Incorporated1.1%-20.4%$144.5M
MOG-AMoog Inc1.0%-5.3%$132.0M
ENTGEntegris Inc1.0%-5.7%$125.3M
APGApi Group Corp1.0%-5.0%$125.2M
TXRHTexas Roadhouse Inc1.0%+0.8%$124.5M
FSSFederal Signal Corp0.9%-3.3%$119.0M
FNFabrinet0.9%+64.2%$118.5M
POWLPowell Inds Inc0.9%+104.5%$117.4M
GMEDGlobus Med Inc0.9%-2.8%$114.8M
COHRCoherent Corp0.9%-0.6%$112.6M
G39108108Gates Indl Corp PLC Ord Shs0.8%-5.0%$107.0M
HALOHalozyme Therapeutics Inc0.8%-2.9%$106.0M
PFGCPerformance Food Group Co0.8%-4.1%$103.7M
BURLBurlington Stores0.8%-4.3%$102.9M
AVGOBroadcom Inc0.8%-19.2%$102.8M
IDAIdacorp Inc0.8%-4.5%$101.1M
MSFTMicrosoft Corp0.8%-1.3%$100.4M
UMBFUmb Finl Corp0.8%-4.1%$96.0M
NBIXNeurocrine Biosciences Inc0.7%-4.4%$95.6M
CVCOCavco Inds Inc Del0.7%-6.0%$94.3M
ESIElement Solutions Inc0.7%-6.7%$92.5M
MEDPMedpace Hldgs Inc0.7%-5.5%$91.5M
NDSNNordson Corp0.7%-6.1%$88.6M
LOPEGrand Canyon Ed Inc0.7%-14.8%$88.3M
VOYAVoya Financial, Inc.0.7%-5.4%$87.3M
AITApplied Indl Technologies in0.7%-5.0%$87.2M
SFStifel Finl Corp0.7%-4.6%$87.0M
FIXComfort Sys USA Inc0.7%-54.2%$86.9M
JBLJabil Inc0.7%-36.4%$84.6M
JAZZJazz Pharmaceuticals PLC0.7%-5.5%$84.5M
BBIOBridgebio Pharma Inc0.7%+16.9%$83.8M
SOISolaris Energy Infrastructure Inc0.7%—$83.5M
VCYTVeracyte Inc0.7%—$83.2M
RHPRyman Hospitality Pptys Inc0.6%—$79.2M
CYTKCytokinetics0.6%—$78.0M
LGNDLigand Pharmaceuticals Inc0.6%—$78.0M
DELLDell Technologies Inc0.6%—$76.2M
MGYMagnolia Oil & Gas Corp0.6%-5.3%$74.6M
CGNXCognex Corp0.6%—$73.9M
BJBjs Whsl Club Hldgs Inc Com0.6%+12.5%$73.0M
CFGCitizens Finl Group Inc0.6%-1.6%$72.4M
PMPhilip Morris Intl Inc0.6%-1.6%$70.8M
DCODucommun Inc Del0.6%—$70.7M
GBCIGlacier Bancorp Inc New0.5%-4.3%$69.5M

What GW&K Investment Management, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+41.0% /yr
S&P 500 +20.1%
3 years
+24.4% /yr
S&P 500 +20.4%
5 years
+11.3% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$12.8B1,084
Q1 2026$11.3B1,013
Q4 2025$11.6B991
Q3 2025$11.3B992
Q2 2025$11.2B985
Q1 2025$10.8B1,004
Q4 2024$11.8B967
Q3 2024$11.7B955
Q2 2024$10.9B935
Q1 2024$11.3B917
Q4 2023$10.7B925
Q3 2023$10.0B908

Questions about GW&K Investment Management, LLC's portfolio

What stocks does GW&K Investment Management, LLC own?

GW&K Investment Management, LLC's latest 13F, for Q2 2026 and filed Aug 12, 2026, lists 1,084 positions worth $12.8B. The largest are Macom Tech Solutions Hldgs I (MTSI) at 1.9%, Advanced Energy Inds Inc (AEIS) at 1.7%, Spx Technologies Inc (SPXC) at 1.4%, Sterling Infrastructure Inc (STRL) at 1.3% and Itt (ITT) at 1.2%.

What did GW&K Investment Management, LLC buy last quarter?

In Q2 2026, GW&K Investment Management, LLC added Powell Inds Inc (POWL) (+104.5% shares), Fabrinet (FN) (+64.2% shares) and Bridgebio Pharma Inc (BBIO) (+16.9% shares), compared with its Q1 2026 filing.

What did GW&K Investment Management, LLC sell last quarter?

In Q2 2026, GW&K Investment Management, LLC cut from its top 50 Insmed Inc (INSM), cut from its top 50 Matador Resources Co. (MTDR), cut from its top 50 Piper Sandler Companies (PIPR), cut from its top 50 Siteone Landscape Supply Inc (SITE), cut from its top 50 Abbvie Inc (ABBV), Comfort Sys USA Inc (FIX) (-54.2% shares), Jabil Inc (JBL) (-36.4% shares) and Sterling Infrastructure Inc (STRL) (-35.1% shares), compared with its Q1 2026 filing.

How has GW&K Investment Management, LLC's portfolio performed?

A portfolio copying GW&K Investment Management, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +24.4% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +41.0% against +20.1%. Over 5 years: +11.3% a year against +11.6%.

When is GW&K Investment Management, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. GW&K Investment Management, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does GW&K Investment Management, LLC manage?

GW&K Investment Management, LLC reported $52.8B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $12.8B.